Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor

Tissue Antigens

Volumn 48, Issue 4 I, 1996, Pages 278-284

  Gumperz, J E ^a   Paterson, J C M ^a   Litwin, V ^b   Valiante, N ^a   Lanier, L L ^c   Parham, P ^a,e   Little, A M ^a,d  

^a STANFORD UNIVERSITY   (United States)

^b A Subsidiary of Lantheus Holdings   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blocking antibody; Class I receptor; Inhibition; NK cell

Indexed keywords

ALANINE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; LYMPHOCYTE RECEPTOR; MONOCLONAL ANTIBODY;

ALLELE; AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOLYSIS; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; LYMPHOBLASTOID CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0029860468     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02646.x     Document Type: Article

References (33)

1. Storkus W, Alexander J, Payne JA, Cresswell P, Dawson JR. Reversal of natural killing susceptibility in target cells expressing transfected class I genes. Proc Natl Acad Sci U S A 1989: 86: 2361-2364.
2. Shimizu Y, DeMars R. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis in inversely correlated with HLA class I antigen expression. Eur J Immunol 1989: 19: 447-451.
3. Moretta A, Vitale M, Bottino C et al. P58 molecules as putative receptors of major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993: 178: 597-604.
4. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994: 180: 537-543.
5. Wagtmann N, Rajagopalan S, Winter C, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995: 3: 801-809.
6. Burshtyn DN, Scharenberg AM, Wagtmann N et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 1996: 4: 77-85.
7. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995: 2: 439-449.
8. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995: 268: 405-408.
9. D'Andre A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier L. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypes. J Immunol 1995: 155: 2306-2310.
10. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995: 181: 1133-1144.
11. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell 1978: 14: 9-20.
12. Trapani JA, Mizuno S, Kang SH, Yang SY, Dupont B. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody. Immunogenetics 1989: 29: 25-32.
13. McMichael A, Parham P, Rust N, Brodsky F. A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum Immunol 1980: 1: 121-129.
14. Arnett KL, Adams EJ, Gumperz JE, et al. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 (B*0802). Tissue Antigens 1995: 46: 316-321.
15. Ellis SA, Taylor C, Hildreth JEK, McMichael AJ. An HLA class I specific monoclonal antibody that fails to bind to all HLA-A antigens. Hum Immunol 1985: 13: 13-19.
16. Parham P, Antonelli P, Herzenberg LA, Kipps TJ, Fuller A, Ward FE. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum Immunol 1986: 15: 44-67.
17. Parham P, Androlewicz MJ, Brodsky FM, Holmes NJ, Ways J. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods 1982: 53: 133-173.
18. Shimizu Y, Geraghty DE, Koller BH, Orr HT, De Mars R. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci U S A 1988: 85: 227-231.
19. Lanier LL, Recktenwald DJ. Multicolor immunofluorescence and flow cytometry. Methods (Orlando) 1991: 2: 192-199.
20. Yang SY. A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis. In: Dupont B, ed. Immunobiology of HLA. Vol. I. New York: Springer-Verlag, 332-335.
21. Little A-M, Parham P. HLA class I gene and protein sequence polymorphisms. In: Dyer P, Middleton D, ed. Histocompatibility testing: a practical approach. The Practical Approach Series. Oxford: IRL Press: 159-190.
22. Yssel H, Devries JE, Koken M, van Blitterswijk W, Spits H. Serum-free medium for the generation and the propagation of functional human cytotoxic and helper T cell clones. J Immunol Methods 1984: 72: 219-227.
23. Barber LD, Percival L, Valiante NM et al. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C. J Exp Med 1996: 184: 735-740.
24. Ways JP, Coppin HL, Parham P. The complete primary structure of HLA-Bw58. J Biol Chem 1985: 260: 11924-11933.
25. Ways JP, Rothbard JB, Parham P. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17. J Immunol 1986: 137: 217-222.
26. Santos-Aguado J, Barbosa JA, Biro PA, Strominger JL. Molecular characterization of serological recognition sites in the human HLA-A2 molecule. J Immunol 1988: 141: 2811-2818.
27. 2-microglobulin association and cell surface expression. Mol Cell Biol 1987: 7: 982-990.
28. Ways JP, Lawlor DA, Wan AM, Parham P. A transposable epitope of HLA-B7, B40 molecules. Immunogenetics 1987: 25: 323-328.
29. McCutcheon JA, Smith KD, Valenzuela A, Aalbers K, Lutz CT. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum Immunol 1993: 36: 69-75.
30. Trinichieri G, Valiante N. Receptors for the Fc fragment of IgG on natural killer cells. Nat Immun 1993: 12: 218-234.
31. Smith KJ, Reid SW, Harlos K et al. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 1996: 4: 215-228.
32. 2 helix in revealed by the crystal structure of HLA-B*3501. Immunity 1996: 4: 203-213.
33. Amit AG, Mariuzza RA, Phillips SEV, Poljak RJ, Three-dimensional structure of an antigen-antibody complex at 2.8Å resolution. Science 1986: 233: 747-753.